mentors & advisors
Money and mentors for startups and small businesses. Investment and funding opportunities for private equity firms and foundations.
ONAMI’s staff includes three part-time Entrepreneurs-in-Residence. Their role is to assist university and startup company teams already involved in ONAMI Commercialization Gap Fund projects and to develop new projects for possible gap funding.
John Brewer, Jr.
Specialties advanced materials, engineering, energy
John’s 28 years in the wireless industry extend across the disciplines of engineering, marketing and executive management. His tenure includes leadership roles at SIGe Semiconductor, where he helped direct the company’s IPO filing and eventual sale to Skyworks Solution. John has a Bachelor of Science in electrical engineering from Santa Clara University.
Phone 503-453-2765 Email email@example.com
Jay Lindquist, Ph.D.
ONAMI Commercialization Director
Jay has over 20 years of experience in developing nanotechnology-based businesses in industries ranging from capital equipment and aerospace to advanced materials. As ONAMI’s commercialization director, he has helped Oregon start-up companies raise over $70 million to date from less than $4 million in Gap funding. Jay holds a Ph.D. in physical chemistry from the University of California, Irvine; an Executive MBA from Stanford University and a Bachelor of Science from the University of Puget Sound.
Phone 503-522-7031 Email firstname.lastname@example.org
Specialties biotechnology/life sciences
Augie’s deep experience in biotechnology and life sciences stems from an 18-year career at Invitrogen Corporation, now part of Life Technologies. Today, he advises start-up and early-stage biotechnology companies on operations management and deal expertise. Augie holds 34 U.S. patents and a Bachelor of Science in biochemistry and cell biology from the University of California, San Diego.
Phone 541-521-8834 Email email@example.com
Specialties life sciences, water
Michael brings broad life science expertise to ONAMI, specifically with operations and venture financing. He was instrumental in facilitating acquisitions, public offerings and venture funding at six early-stage companies spanning the therapeutics, diagnostics, life science tools, health care services and medical devices markets. Michael has Bachelor of Science degrees in chemistry from Reed College and the University of Washington, as well as an MBA from the Sloan School at MIT.